Difficulty: Medium
Average Score: 76%
Practice
Which neurotransmitter has the maximum number of receptor subtypes?
Correct answer
C
Rationale
In pharmacology, understanding neurotransmitters and their receptor subtypes is crucial for comprehending the effects of CNS drugs. The correct answer to the question is C) Serotonin. Serotonin, also known as 5-HT, has the maximum number of receptor subtypes among the options provided. This is important because the diversity of serotonin receptors allows for a wide range of pharmacological actions in the central nervous system.
GABA (Option A) is an inhibitory neurotransmitter, but it has fewer receptor subtypes compared to serotonin. Glutamate (Option B) is the primary excitatory neurotransmitter in the CNS, but it also has fewer receptor subtypes than serotonin. Substance P (Option D) is involved in pain transmission, but it has a limited number of receptor subtypes compared to serotonin.
Educationally, knowing the diversity of serotonin receptors is essential for understanding the complex actions of serotonergic drugs such as SSRIs, which are commonly used in the treatment of depression and anxiety disorders. Understanding neurotransmitter receptor subtypes can help in predicting drug effects, potential side effects, and in developing more targeted pharmacological interventions for various CNS disorders.
GABA (Option A) is an inhibitory neurotransmitter, but it has fewer receptor subtypes compared to serotonin. Glutamate (Option B) is the primary excitatory neurotransmitter in the CNS, but it also has fewer receptor subtypes than serotonin. Substance P (Option D) is involved in pain transmission, but it has a limited number of receptor subtypes compared to serotonin.
Educationally, knowing the diversity of serotonin receptors is essential for understanding the complex actions of serotonergic drugs such as SSRIs, which are commonly used in the treatment of depression and anxiety disorders. Understanding neurotransmitter receptor subtypes can help in predicting drug effects, potential side effects, and in developing more targeted pharmacological interventions for various CNS disorders.